Comparative bioavailability of four commercial quinidine sulfate tablets

Jeffrey D. Strum, John Colaizzi, James M. Jaffe, Perry C. Martineau, Rolland I. Poust

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A comparative bioavailability study was performed using four commercially available, chemically equivalent brands of quinidine sulfate tablets. Two 200‐mg tablets were administered to 11 different subjects following a completely randomized crossover design. Serum levels, urinary excretion data, and derived pharmacokinetic parameters were compared statistically. There were no statistical differences in the extent of quinidine absorption from the four brands of tablets as evidenced by the cumulative urinary excretion values and the areas under the serum level‐time curves. Significant differences in the mean serum levels at 0.5 and 1 hr and differences in the peak times and absorption rate constants indicate that there was a difference in the absorption rate between Treatments A and D and C and D. A significant difference in the peak times also was noted for Treatments B and C. When mean disintegration times for the four tablet formulations were compared with their values for ka, tmax, and mean serum levels at 0.5 and 1 hr, rank‐order correlations were observed. A considerable degree of variability in quinidine elimination was noted, with half‐life values ranging from 2.71 to 8.12 hr (mean half‐life of 5.36 hr).

Original languageEnglish (US)
Pages (from-to)539-542
Number of pages4
JournalJournal of Pharmaceutical Sciences
Volume66
Issue number4
DOIs
StatePublished - Jan 1 1977

Fingerprint

Quinidine
Biological Availability
Tablets
Serum
Half-Life
Dilatation and Curettage
Cross-Over Studies
Pharmacokinetics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Keywords

  • Bioavailability—quinidine sulfate, four commercial tablets compared, humans
  • Cardiac depressants—quinidine sulfate, bioavailability of four commercial tablets compared, humans
  • Quinidine sulfate—bioavailability of four commercial tablets compared, humans

Cite this

Strum, Jeffrey D. ; Colaizzi, John ; Jaffe, James M. ; Martineau, Perry C. ; Poust, Rolland I. / Comparative bioavailability of four commercial quinidine sulfate tablets. In: Journal of Pharmaceutical Sciences. 1977 ; Vol. 66, No. 4. pp. 539-542.
@article{0943828be8a1424da37875e3495c3c35,
title = "Comparative bioavailability of four commercial quinidine sulfate tablets",
abstract = "A comparative bioavailability study was performed using four commercially available, chemically equivalent brands of quinidine sulfate tablets. Two 200‐mg tablets were administered to 11 different subjects following a completely randomized crossover design. Serum levels, urinary excretion data, and derived pharmacokinetic parameters were compared statistically. There were no statistical differences in the extent of quinidine absorption from the four brands of tablets as evidenced by the cumulative urinary excretion values and the areas under the serum level‐time curves. Significant differences in the mean serum levels at 0.5 and 1 hr and differences in the peak times and absorption rate constants indicate that there was a difference in the absorption rate between Treatments A and D and C and D. A significant difference in the peak times also was noted for Treatments B and C. When mean disintegration times for the four tablet formulations were compared with their values for ka, tmax, and mean serum levels at 0.5 and 1 hr, rank‐order correlations were observed. A considerable degree of variability in quinidine elimination was noted, with half‐life values ranging from 2.71 to 8.12 hr (mean half‐life of 5.36 hr).",
keywords = "Bioavailability—quinidine sulfate, four commercial tablets compared, humans, Cardiac depressants—quinidine sulfate, bioavailability of four commercial tablets compared, humans, Quinidine sulfate—bioavailability of four commercial tablets compared, humans",
author = "Strum, {Jeffrey D.} and John Colaizzi and Jaffe, {James M.} and Martineau, {Perry C.} and Poust, {Rolland I.}",
year = "1977",
month = "1",
day = "1",
doi = "https://doi.org/10.1002/jps.2600660420",
language = "English (US)",
volume = "66",
pages = "539--542",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

Comparative bioavailability of four commercial quinidine sulfate tablets. / Strum, Jeffrey D.; Colaizzi, John; Jaffe, James M.; Martineau, Perry C.; Poust, Rolland I.

In: Journal of Pharmaceutical Sciences, Vol. 66, No. 4, 01.01.1977, p. 539-542.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparative bioavailability of four commercial quinidine sulfate tablets

AU - Strum, Jeffrey D.

AU - Colaizzi, John

AU - Jaffe, James M.

AU - Martineau, Perry C.

AU - Poust, Rolland I.

PY - 1977/1/1

Y1 - 1977/1/1

N2 - A comparative bioavailability study was performed using four commercially available, chemically equivalent brands of quinidine sulfate tablets. Two 200‐mg tablets were administered to 11 different subjects following a completely randomized crossover design. Serum levels, urinary excretion data, and derived pharmacokinetic parameters were compared statistically. There were no statistical differences in the extent of quinidine absorption from the four brands of tablets as evidenced by the cumulative urinary excretion values and the areas under the serum level‐time curves. Significant differences in the mean serum levels at 0.5 and 1 hr and differences in the peak times and absorption rate constants indicate that there was a difference in the absorption rate between Treatments A and D and C and D. A significant difference in the peak times also was noted for Treatments B and C. When mean disintegration times for the four tablet formulations were compared with their values for ka, tmax, and mean serum levels at 0.5 and 1 hr, rank‐order correlations were observed. A considerable degree of variability in quinidine elimination was noted, with half‐life values ranging from 2.71 to 8.12 hr (mean half‐life of 5.36 hr).

AB - A comparative bioavailability study was performed using four commercially available, chemically equivalent brands of quinidine sulfate tablets. Two 200‐mg tablets were administered to 11 different subjects following a completely randomized crossover design. Serum levels, urinary excretion data, and derived pharmacokinetic parameters were compared statistically. There were no statistical differences in the extent of quinidine absorption from the four brands of tablets as evidenced by the cumulative urinary excretion values and the areas under the serum level‐time curves. Significant differences in the mean serum levels at 0.5 and 1 hr and differences in the peak times and absorption rate constants indicate that there was a difference in the absorption rate between Treatments A and D and C and D. A significant difference in the peak times also was noted for Treatments B and C. When mean disintegration times for the four tablet formulations were compared with their values for ka, tmax, and mean serum levels at 0.5 and 1 hr, rank‐order correlations were observed. A considerable degree of variability in quinidine elimination was noted, with half‐life values ranging from 2.71 to 8.12 hr (mean half‐life of 5.36 hr).

KW - Bioavailability—quinidine sulfate, four commercial tablets compared, humans

KW - Cardiac depressants—quinidine sulfate, bioavailability of four commercial tablets compared, humans

KW - Quinidine sulfate—bioavailability of four commercial tablets compared, humans

UR - http://www.scopus.com/inward/record.url?scp=0017368521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017368521&partnerID=8YFLogxK

U2 - https://doi.org/10.1002/jps.2600660420

DO - https://doi.org/10.1002/jps.2600660420

M3 - Article

VL - 66

SP - 539

EP - 542

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 4

ER -